AptarGroup Inc (ATR)
Aptar - Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
United Therapeutics Corporation (UTHR)
UTHR: Notification
Clearpoint Neuro Inc (CLPT)
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe
RedHill Biopharma (RDHL)
Movano Inc. (MOVE)
Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads
RedHill Biopharma (RDHL)
10X Genomics Inc (TXG)
10x Genomics - 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
IQVIA Holdings Inc. (IQV)
IQVIA - IQVIA Named to the Fortune® World’sMost Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year
Abcellera Biologics Inc (ABCL)
Press Release: AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
agilon health Inc (AGL)
agilon health - agilon health Sets Date to Report Fourth Quarter and Full Year 2025 Financial Results
Perimeter Solutions SA (PRM)
Perimeter Solutions Completes Acquisition of MMT
Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
CVRx Inc. (CVRX)
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
Intuitive Surgical Inc (ISRG)
Intuitive Announces Fourth Quarter Earnings
Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026